Related Experiment Video
Updated: Jun 2, 2026

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Bleeding and management of coagulopathy
Roman M Sniecinski1, Jerrold H Levy
1Department of Anesthesiology, Emory University School of Medicine, Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, GA 30322, USA.
Managing bleeding after cardiac surgery is crucial. Point-of-care testing and multimodal strategies, including antifibrinolytics and specific coagulation products, can improve outcomes and reduce transfusions.
Area of Science:
- Cardiology
- Hematology
- Anesthesiology
Background:
- Post-cardiac surgery bleeding is a major complication, increasing hospital stay and mortality.
- Coagulopathy evaluation is hindered by slow standard coagulation tests.
- Factors include dilutional coagulopathy, fibrinolysis, and platelet dysfunction.
Purpose of the Study:
- To review current strategies for managing bleeding and coagulopathy in cardiac surgery.
- To highlight the utility of point-of-care testing and transfusion protocols.
- To discuss the role of pharmacologic agents and novel coagulation products.
Main Methods:
- Review of literature on bleeding management in cardiac surgery.
- Discussion of point-of-care testing modalities like thromboelastography.
- Analysis of transfusion protocols and pharmacologic interventions.
Main Results:
- Point-of-care testing algorithms can potentially reduce transfusion needs.
- Massive transfusion protocols are relevant for complex aortic surgery.
- Multimodal management incorporating antifibrinolytics and specific coagulation products is essential.
Conclusions:
- Effective management requires a multimodal approach tailored to the patient.
- Early recognition and treatment of coagulopathy are key.
- Emerging recombinant and purified coagulation products offer targeted therapeutic options.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation